What is Arimidex? Arimidex is a non-steroidal aromatase inhibitor used in the treatment of breast cancer, particularly hormone receptor-positive breast cancer. It has a high affinity for androgen receptors, which are responsible for the growth and proliferation of the cancer cells. It is a selective inhibitor of the aromatase enzyme. In clinical studies, Arimidex has been shown to be effective in the treatment of early-stage breast cancer. The active ingredient in Arimidex is anastrozole, which is anastrozole, and it is also the main ingredient in aromatase inhibitors. It is used for the treatment of breast cancer in women who have undergone hormone treatment or are in the early stages of treatment, such as those who are at high risk of breast cancer. This medicine is also used in combination with other medications to treat breast cancer. Arimidex is approved for use in women who are at least 20 years of age and have hormone therapy or have undergone treatment for hormone receptor-positive breast cancer. In addition, Arimidex can also be used in combination with other medicines. The active ingredient in Arimidex is a selective inhibitor of aromatase, which is involved in the production of oestrogen. Arimidex is also used in the treatment of hormone receptor-positive breast cancer in women who are at least 20 years of age and have hormone therapy or treatment for hormone receptor-positive breast cancer. In addition, Arimidex is also used in combination with other medicines to treat breast cancer in women who have undergone treatment with tamoxifen or anastrozole. Arimidex is a synthetic version of the compound aromatase inhibitor. This medicine is used for the treatment of breast cancer in women who have undergone treatment with tamoxifen or anastrozole. Arimidex is available in capsule form and is taken by mouth. It should be used for the treatment of hormone receptor-positive breast cancer in women who are at least 20 years of age and have undergone treatment with tamoxifen or anastrozole. Arimidex is also available in tablet form and is taken by mouth. Arimidex is not intended for the treatment of breast cancer. The active ingredient in Arimidex is anastrozole, which is a synthetic version of the compound aromatase inhibitor. It is also used in the treatment of hormone receptor-positive breast cancer in women who are at least 20 years of age and have undergone treatment with tamoxifen or anastrozole. The active ingredient in Arimidex is a synthetic version of the compound aromatase inhibitor. This medicine is used in the treatment of hormone receptor-positive breast cancer in women who are at least 20 years of age and have undergone treatment with tamoxifen or anastrozole. Arimidex is also available in capsule form and is taken by mouth.
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
MedicinalEffectivenessProduct information about using Arimidex Anastrozole (1mg) 30 TabletsMedicinal Effectiveness (E4)1mg30 tablets
30 tablets of Arimidex Anastrozole (1 mg) 30 TabletsMedicinal Benefits (E4)
Product Name:Anastrozole (Arimidex) Medication
Manufacturer:AstraZeneca
Product Type
Company:
Company Address:AstraZeneca International Medical Center, Paine Hall, Ontario, H1N1 10D0
Phone:1775-639-4748, +1-800-486-APRA
Driving licence
Anastrozole (Arimidex) is used to reduce the risk of certain types of breast cancer in postmenopausal women. The drug has been shown to reduce the risk of invasive breast cancer in postmenopausal women. Anastrozole (Arimidex) works by lowering estrogen levels in the body.
Anastrozole (Arimidex) is a medication that is used to reduce the risk of certain types of breast cancer in postmenopausal women. The drug has been shown to reduce the risk of the breast cancer, and this risk has been shown to increase with increasing doses. Anastrozole (Arimidex) is available in the following brands:
Anastrozole (Arimidex) belongs to a class of drugs called aromatase inhibitors. Anastrozole (Arimidex) lowers estrogen levels by reducing the activity of an enzyme called aromatase. When taken as directed, anastrozole (Arimidex) may reduce the amount of estrogen produced in the body. This decrease in estrogen could lead to an increase in the amount of breast tissue that can develop cancer. In order to prevent cancer from developing, anastrozole (Arimidex) should be taken only as prescribed by your doctor.
Anastrozole (Arimidex) is a prescription medication. To learn more, contact a health care provider.
This medicine is only for use in Adults:
Product Label/Other Information:Arimidex is an aromatase inhibitor medication that lowers estrogen levels in women. Arimidex is also used to reduce the risk of certain types of breast cancer in postmenopausal women. Anastrozole (Arimidex) has been shown to reduce the risk of certain types of breast cancer in postmenopausal women. This medicine is only for use in Adults: Product Label/Other Information: This product is for the treatment of breast cancer in postmenopausal women. If you have any questions regarding the product or use of this medication, contact your health care provider or visit our customer service center. We carry an extensive list of brands and dosages of medicines for both prescription and over the counter.
Company Product:Arimidex
Active Ingredients:Anastrozole (Arimidex) 30mg/1.25mg
Contains:100% Anastrozole (Arimidex)
Strength:100 mg
Manufacturer Information:
Chemical Class:Aromat Edited
500 mg
Manufacturer/Marketer:
Country of Origin:United Kingdom
Shipping/Arranging:Express Shipping, UPS, FedEx
Prescription/Non-Non-Prescription/Out-of-Time (NIT) Service:Non-Insurance Prescription Prescription
Made in India
Driving license
Arimidex (Arimidex) lowers estrogen levels in women by reducing the activity of an enzyme called aromatase.
Anastrozole Tablet is an anti-estrogen drug, which is used to treat breast cancer in women by controlling estrogen levels in the body. This medicine is also used to treat hormone receptor-positive breast cancer and advanced breast cancer in women who have received radiation therapy. Anastrozole Tablet can be used for treating hormone receptor-positive breast cancer in postmenopausal women. It is also used to treat advanced breast cancer in women who have received radiation therapy. Anastrozole Tablet may help prevent recurrence of breast cancer in postmenopausal women.
Ajanta Pharma
is an Indian company that produces pharmaceutical and other pharmaceutical products. The main brands of Ajanta Pharma include Anastrozole Tablet, Anastrozole HCl, Arimidex Tablet, Anastrozole XR, Arimidex HCT, Arimidex XR, Anastrozole Tablets, Anastrozole Tablets Injection, Arimidex Tablet Injection, Arimidex XR Injection, Arimidex Tablet Injection, Anastrozole Tablets, Arimidex Tablet Injection 100, Arimidex Tablet Injection, Arimidex Tablet Injection, Arimidex HCT Injection, Arimidex XR Injection, Arimidex Tablet Injection, Arimidex Tablet Injection, Arimidex Tablet Injection Injection, Arimidex Tablet Injection 100, Arimidex Tablet Injection, Anastrozole Tablet Injection, Arimidex Tablet Injection Injection, Arimidex Tablet Injection Injection
Anastrozole Tablet is used to reduce the risk of breast cancer in postmenopausal women. It can be used alone or in combination with other medications. It is also used to prevent recurrence of breast cancer in postmenopausal women.
The dosage of Anastrozole Tablet is taken orally once or twice daily. The dosage of Anastrozole Tablet in children is 0.1 to 1 mg/day and the dosage in adults is 1 to 2.5 mg/day. It is taken by mouth once or twice a day. The treatment may be started when the patient is between 45 to 60 minutes before the activity of the drugs. The dosage of Anastrozole Tablet in children is 1 to 2 mg/day. The treatment can be started when the patient is between 45 to 60 minutes before the activity of the drugs. The treatment may be started when the patient is between 1 to 3 years of age and the treatment can be started when the patient is between 1 to 5 years of age.
The side effects of Anastrozole Tablet may include the following:
The Interactions with Anastrozole Tablet may cause the medicines to have very low levels of the medicines.
Arimidex is a medication that was developed by AstraZeneca as a treatment for women who had undergone hormone replacement therapy. However, the drug is being used as a treatment for breast cancer, and it has been approved for use in Australia for the treatment of breast cancer.
The company is currently evaluating whether the drug could be used in Australia for patients who have undergone hormone therapy for breast cancer or if it is an appropriate use for the treatment of these patients.
The company is currently conducting a review of its clinical trial data and looking at the potential use of the drug in patients who have undergone hormone replacement therapy for breast cancer. If the results of the trial are confirmed, the company will be investigating whether it can continue to offer the medication for these patients.
Arimidex is not a cure for hormone therapy and will continue to be available as a treatment for breast cancer. The company is looking at other options to consider.
Arimidex is marketed in the USA under the brand name Arimidex and is available in Australia as a generic medication and a brand name. The company is currently evaluating whether the drug could be used in Australia for women who have undergone hormone therapy for breast cancer.
If approved by the Food and Drug Administration (FDA), Australia would be the first country to have a drug approved for use in women who have undergone hormone replacement therapy for breast cancer. It has been approved for use in women with breast cancer and in the treatment of other types of cancer.
Arimidex is a medication that is used to treat female hormone receptor-positive breast cancer. It has been approved for use in women who have undergone hormone therapy for breast cancer and in the treatment of other types of breast cancer. However, it is being used as an adjuvant therapy for hormone receptor-positive breast cancer.
Arimidex has also been used in the treatment of breast cancer and has been approved to treat other types of breast cancer. It has been approved to treat breast cancer in women who have undergone hormone therapy for breast cancer.
The drug is being studied in other countries as well. It is being evaluated in Australia for women who have undergone hormone therapy for breast cancer.
Read MoreArimidex is a medication that was developed by AstraZeneca as a treatment for women who had undergone hormone replacement therapy for breast cancer. The drug was approved for use in Australia for the treatment of women who had undergone hormone therapy for breast cancer. The drug is being used as an adjuvant therapy for breast cancer.
It is being used as an adjuvant therapy for breast cancer.
The drug is being evaluated in Australia for women who have undergone hormone therapy for breast cancer. It has been approved for use in women who have undergone hormone therapy for breast cancer. The drug is being evaluated as an adjuvant therapy for breast cancer.
Arimidex is being evaluated in Australia for women who have undergone hormone therapy for breast cancer.
Arimidex is a medication that was developed by AstraZeneca as a treatment for women who had undergone hormone therapy for breast cancer.